SAN FRANCISCO — The U.S. Court of Appeals for the Federal Circuit has turned down a pharmaceutical company’s plea to elevate a forum selection clause above judicial economy in assigning a patent case.
Despite recent signals from the Supreme Court about respecting forum selection clauses, the Federal Circuit summarily denied a 42-page petition for writ of mandate by Eli Lilly & Co. seeking to keep its case against Genentech and City of Hope in the Northern District of California, rather than having it sent to U.S. District Judge Mariana Pfaelzer of Los Angeles.
